Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium electroporation in esophageal cancer
NCT04958044Phase 1Completed
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of calcium gluconate in esophageal cancer. Primary endpoint: Safety and Adverse Events at 14 days. Started May 2021; status: completed.
02
Drugs
calcium gluconate
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT04958044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04958044.